Active Ingredient(s):Lomitapide Medylate FDA Approved: * December 21, 2012 Pharm Company: *AEGERION PHARMACEUTICALS INC Category:Cholesterol
Lomitapide , sold under the brand name Juxtapid in the US and as Lojuxta in the EU) is a medication used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by Aegerion Pharmaceuticals.
It has been tested in clinical trials as single treatment and in combinations with atorvastatin, ezetimibe and fenofibrate.
The US Food and Drug Administration (FDA) approved lomitapide on 21 December 2012, as an orph...
* May have multiple approval dates, manufacturers, or labelers.